Proteasome activator enhances survival of Huntington's disease neuronal model cells.
In patients with Huntington's disease (HD), the proteolytic activity of the ubiquitin proteasome system (UPS) is reduced in the brain and other tissues. The pathological hallmark of HD is the intraneuronal nuclear protein aggregates of mutant huntingtin. We determined how to enhance UPS functio...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2007-02-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC1800909?pdf=render |